Global Stem Cell Therapy Market

Stem Cell Therapy Market Size, Share, Growth Analysis, By Therapy(Autologous, and Allogenic), By Application(Neurological Disorders, Orthopedic Treatments, Oncology Disorders, Injuries and Wounds), By Cell source(Adipose tissue derived mscs, Bone marrow derived mscs, Placental cord-derived mscs, Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2162 | Region: Global | Published Date: June, 2024
Pages: 219 |Tables: 93 |Figures: 76

Stem Cell Therapy Market Insights

Global Stem cell therapy Market size was valued at USD 12.11 Billion in 2022 and is poised to grow from USD 13.33 Billion in 2023 to USD 28.79 Billion by 2031, at a CAGR of 10.1% during the forecast period (2024-2031). 

The primary purpose of the stem cell therapy market is to provide innovative treatment options for a wide range of medical conditions. Stem cell therapies aim to address diseases and injuries that have limited or no effective treatment options currently available. By harnessing the regenerative properties of stem cells, this market seeks to offer hope to patients suffering from conditions such as cardiovascular diseases, neurodegenerative disorders, orthopedic injuries, autoimmune diseases, and certain types of cancer. the growth of the global stem cell therapy market. One of the key drivers is the increasing prevalence of chronic diseases and age-related conditions.

One of the primary challenges is the high cost associated with stem cell therapies. The stem cell therapy market faces several challenges. One of the key challenges is the need for standardization and regulation. As stem cell therapies evolve, it becomes essential to establish clear guidelines and standards for their development, manufacturing, and clinical application. The market faces challenges related to scalability and cost-effectiveness. Scaling up the production of stem cell therapies to meet the demand while maintaining quality and reducing costs remains a significant hurdle. the challenges, the stem cell therapy market offers significant opportunities. The expanding pipeline of clinical trials and research studies exploring the potential of stem cell therapies indicates a promising future.

Market Snapshot - 2024-2031

Global Market Size

USD 12.11 Billion

Largest Segment

Allogenic

Fastest Growth

Allogenic

Growth Rate

10.1% CAGR

Global Stem Cell Therapy Market 2022-2030 ($ Bn)
Country Share for North America Region- 2022 (%)

To get more reports on the above market click here to Buy The Report

Stem Cell Therapy Market Segmental Analysis

The global stem cell therapy market is segmented on the therapy, application, and region. In terms of therapy, the market is segmented into autologous, and allogeneic. With respect to classification by application, the market is segmented into regenerative medicine, drug discovery and development. On the basis of cell source the market is segmented into Adipose tissue derived mscs, bone marrow derived mscs, placental cord-derived mscs and other. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.  

Stem Cell Therapy Market Analysis by Therapy

In 2022, the allogeneic therapy segment dominated the stem cell therapy market. capturing a significant market share of 59.14% in terms of revenue generation. This growth can be attributed to factors such as higher pricing of allogeneic therapies and the increasing popularity of stem cell banking. Many companies in the cell therapy sector are focusing on developing allogeneic cell therapy products, further contributing to the growth of this segment. strategic initiatives by key market players aimed at strengthening their product portfolios are expected to create lucrative opportunities during the review period. For example, Acepodia secured USD 47 million in Series B financing in March 2021 to advance its pipeline of allogeneic cell therapy candidates. Additionally, Immatics and Bristol Myers Squibb expanded their strategic alliance in June 2022 to develop gamma delta allogeneic cell therapy programs.

The autologous therapy segment is projected to witness substantial growth throughout the forecast period. This is primarily due to the lower risk of complications associated with autologous treatments. Other factors driving the growth of this segment include affordability, improved patient survival rates, the absence of the need to identify an HLA-matched donor, and a reduced risk of graft-versus-host diseases. Autologous mesenchymal stem cells (MSCs) are also being investigated for their potential in treating osteoarthritis, as they can differentiate into cartilage and bone tissues.

Stem Cell Therapy Market Analysis by Application

Neurological Disorders Stands as the largest segment, captivating both researchers and patients alike with its transformative possibilities. these developments above reveal how stem cells therapy have greatly impacted upon managing disorders such as Parkinson's, Alzheimer's and spinal cord injuries Stem cell treatment provides an essential relief for millions people pursuing a comprehensive solution beyond a simple symptomatic treatment and even a ‘regeneration’ and ‘restoration’ of neural function. As the world is facing this surge in aging population, the treatment of neurological disorders becomes increasingly important; the investment increases and the research is in phenomena of the age of intellectual advancement and new discoveries is initiated in this area.

Oncology Disorders is the fastest growing segment in this market. In order to explain the development of cancer cells in this universe, this realm of stem cell therapy which is experiencing an explosive escalation due to its mission to change the set of rules of cancer treatment. Stem cells may be incrementally stepping into the role of "personalized, targeted therapies" employing the approach of exact tumor localization and restoration of healthy tissues after the treatment. As cancer stalks the world without a touch of mercy, fostering stem-cell-based innovations gains increased traction in the medical spectrum, bringing this segment at the prime of the medical frontier. With each breakthrough, the boundaries of what's possible in cancer care blur, underscoring the profound impact of stem cell therapy on the oncological landscape.

Stem Cell Therapy Market Analysis by Cell source 

Adipose Tissue-Derived MSCs (AD-MSCs) are rather prospective owing to their availability. It is easier to acquire a large number of stem cells for possible treatments because the fat tissues are easily accessible. AD-MSCs have been shown to have therapeutic promise in healing osteoarthritis, cardiovascular diseases, Crohn’s disease, and many other ailments. Also, access to AD-MSCs is easier compared to other sources since it entails minimal invasive extraction among patients. 
 
Shipped directly from the patients’ own body, BM-MSCs are considered as the most characterized and explored type of MSC for therapeutic purposes. Literature has established their possibilities of using them to treat different sicknesses such as bone regeneration, Graft-Versus-Host-Disease (GVDH), and neurological diseases. However, the procurement of bm-MSCs requires more painful bone marrow aspiration procedure than other sources ofMSCs. 
 
UC-MSCs derived from the placental cord are obtained non-invasively and ethically unlike other stem cells. These MSCs are harvested from the umbilical cord after the birth of a child without the necessity for further operations. UC-MSCs have a high proliferation capacity; this may be somewhat interpreted as meaning they can be more easily propagated in a controlled laboratory environment as compared to some other UC sources of MSCs. Moreover, they have great immunomodulating effects hence they could be used in those forms of treatments that involve controlling the body’s immune system. 

Global Stem Cell Therapy Market Size By Therapy, 2022(%), 2022 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Stem Cell Therapy Market Regional Insights

In 2022, North America dominated the stem cell therapy market with the largest revenue share of 44.56%. This can be attributed to several factors, including the presence of innovative companies and key market players in the region, leading to a higher penetration of stem cell therapy products. North America is known for its strong biotechnology industry, extensive research and development activities, and a focus on promoting personalized medicines. These factors contribute to the region's leading position in the market. Additionally, the growth in North America is further supported by government initiatives aimed at promoting stem cell therapies.

Asia Pacific is expected to exhibit rapid growth in the stem cell therapy market, with a projected compound annual growth rate (CAGR) of 16.09% during the period of 2023-2030. This growth is driven by factors such as strong product pipelines of stem cell-based therapies and a large patient population base in the region. The incidence rate of diseases like cancer, neurological disorders, and diabetes is increasing, creating a demand for advanced treatments such as stem cell therapies. Furthermore, governments in the Asia Pacific region are actively funding and supporting stem cell research to accelerate advancements in the field.

Global Stem Cell Therapy Market Size By Geography, 2022-2030, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Stem Cell Therapy Market Dynamics

Global Stem Cell Therapy Market Drivers

Increasing Prevalence of Chronic Diseases

  • The rising burden of chronic diseases, such as cardiovascular disorders, neurodegenerative conditions, and orthopedic injuries, is a significant driver for the stem cell therapy market. Stem cell therapies offer the potential to regenerate damaged tissues and organs, providing new treatment options for patients with limited or no effective alternatives.

Technological Advancements and Research Investments

  • Advances in stem cell research and technologies have expanded the understanding of stem cells and their applications. The development of novel methods for cell isolation, expansion, and differentiation, as well as genetic engineering techniques, have propelled the field forward. Increased investments in stem cell research by governments, academic institutions, and private companies have accelerated the pace of innovation.

Global Stem Cell Therapy Market Restraints

High Treatment Costs

  • The high cost associated with stem cell therapies poses a significant barrier to widespread adoption. The research and development efforts, manufacturing complexities, and regulatory requirements contribute to the high price of these therapies. This limits access to stem cell treatments for many patients, particularly in lower-income regions.

Ethical and Regulatory Challenges

  • The ethical considerations surrounding the use of certain types of stem cells, such as embryonic stem cells, have limited their widespread acceptance and funding. Additionally, navigating the regulatory landscape and ensuring compliance with various regulations for clinical trials and commercialization of stem cell therapies can be complex and time-consuming.

Request Free Customization of this report to help us to meet your business objectives.

Stem Cell Therapy Market Competitive Landscape

The Global Stem cell therapy Market is highly competitive, with several key players operating in the industry. These companies are actively involved in research and development, strategic collaborations, mergers and acquisitions, and product launches to gain a competitive edge in the market. Here are some prominent players in the stem cell therapy market. The market is dynamic and competitive, with ongoing advancements and new entrants continually shaping the landscape. It is worth noting that the competitive landscape may evolve over time as companies pursue strategic collaborations, expand their product portfolios, and introduce new therapies to address unmet medical needs.

Top Player’s Company Profiles in Stem Cell Therapy Market

  • Mesoblast Limited (Australia)
  • Celgene Corporation (a subsidiary of Bristol Myers Squibb) (US)
  • TiGenix NV (a subsidiary of Takeda Pharmaceutical Company Limited) (Belgium)
  • Gamida Cell Ltd. (Israel)
  • Vericel Corporation (US)
  • Medipost Co., Ltd. (South Korea)
  • Astellas Pharma Inc. (Japan)
  • Osiris Therapeutics, Inc. (US)
  • NuVasive, Inc. (US)
  • Cynata Therapeutics Limited (Australia)
  • Cellular Dynamics International (a subsidiary of FUJIFILM Holdings Corporation) (US)
  • Lonza Group Ltd. (Switzerland)
  • Caladrius Biosciences, Inc. (US)
  • Athersys, Inc. (US)
  • Cytori Therapeutics, Inc. (US)
  • Holostem Terapie Avanzate S.r.l. (Italy)
  • Pluristem Therapeutics Inc. (Israel)
  • BioTime, Inc. (US)

Stem Cell Therapy Market Recent Developments

  • In April 2024, Market research reports predict the global stem cell therapy market to reach a value exceeding USD 25 billion by 2030, fueled by increasing investment and ongoing clinical trials. 

  • In Jan 2024, Researchers successfully sent stem cells to the International Space Station (ISS) for a two-week study. The aim is to understand how microgravity affects stem cell behavior, potentially leading to improved therapies on Earth. 

  • In late 2023, Several late-stage clinical trials for stem cell therapies targeting various conditions like Parkinson's disease, multiple sclerosis, and heart failure reported positive results, raising hopes for potential future approvals. 

  • In December 2023 to create cellular treatment goods, services, and testing, GenCure and the University of Texas at San Antonio (UTSA) partnered.

  • A contract for the research, development, and production of iPSC-derived regulatory T cells (Tregs) with potential therapeutic applications was signed in August 2023 by BlueRock Therapeutics LP and bit.bio.

  • In July 2023, PromoCell GmbH introduced the PromoExQ MSC Growth Medium XF, which enables the consistent growth and maintenance of multipotent human mesenchymal stem cells (hMSCs) in vitro within a controlled environment.

  • Pluristyx, Inc. and Stem Genomics collaborated in July 2023. Through this collaboration, the Stem Genomics iCS-digital PSC assay will be used to assess the genomic stability of Pluristyx's pluripotent stem cell (PSC) lines.

  • June of 2023 The human induced pluripotent stem cell (iPSC) producer, FUJIFILM Cellular Dynamics, has announced the release of their iCell Blood-Brain Barrier Isogenic Kit, designed for scientists who are involved in the drug development process for neuroactive pharmaceuticals. The kit can improve medication development, discovery, and medical research for disorders of the central nervous system (CNS) since it maintains barrier integrity.

Stem Cell Therapy Key Market Trends

  • Increased Focus on Allogeneic Therapies: Allogeneic stem cell therapies, which use cells from a donor, have gained traction in the market. This approach offers advantages such as standardized and readily available cell sources, reduced manufacturing costs, and potential off-the-shelf treatments. Many companies are shifting their focus towards developing allogeneic cell therapy products, leading to an expanding pipeline of clinical trials and product development in this area.
  • Personalized Medicine and Cell Banking: Personalized medicine, tailoring treatments to individual patients based on their unique characteristics, is gaining prominence in the stem cell therapy market. Cell banking, including the collection and storage of patients' own cells for future therapeutic use, is becoming increasingly important. This approach enables personalized and timely treatment options, particularly in autologous therapies, where a patient's own cells are used.

Stem Cell Therapy Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our analyses, the global stem cell therapy market is expected to be driven by the rising prevalence of chronic diseases, increasing investment in stem cell research, and growing demand for regenerative medicine. The market growth is driven by several factors, including the increasing prevalence of chronic diseases, growing investment in stem cell research and development, advancements in stem cell technologies, and rising government support for stem cell therapies. The global stem cell therapy market is highly competitive with the presence of several players. The government of India set up state-of-the-art stem cell research facilities in 40 leading health research and educational institutions, which is expected to accelerate research in the field.

Report Metric Details
Market size value in 2022 USD 12.11 Billion
Market size value in 2031 USD 28.79 Billion
Growth Rate 10.1%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Therapy
    • Autologous, and Allogenic
  • Application
    • Neurological Disorders, Orthopedic Treatments, Oncology Disorders, Injuries and Wounds, Cardiovascular Disorders, and Others
  • Cell source
    • Adipose tissue derived mscs, Bone marrow derived mscs, Placental cord-derived mscs, Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Mesoblast Limited (Australia)
  • Celgene Corporation (a subsidiary of Bristol Myers Squibb) (US)
  • TiGenix NV (a subsidiary of Takeda Pharmaceutical Company Limited) (Belgium)
  • Gamida Cell Ltd. (Israel)
  • Vericel Corporation (US)
  • Medipost Co., Ltd. (South Korea)
  • Astellas Pharma Inc. (Japan)
  • Osiris Therapeutics, Inc. (US)
  • NuVasive, Inc. (US)
  • Cynata Therapeutics Limited (Australia)
  • Cellular Dynamics International (a subsidiary of FUJIFILM Holdings Corporation) (US)
  • Lonza Group Ltd. (Switzerland)
  • Caladrius Biosciences, Inc. (US)
  • Athersys, Inc. (US)
  • Cytori Therapeutics, Inc. (US)
  • Holostem Terapie Avanzate S.r.l. (Italy)
  • Pluristem Therapeutics Inc. (Israel)
  • BioTime, Inc. (US)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Stem Cell Therapy Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Stem Cell Therapy Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Stem Cell Therapy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Stem Cell Therapy Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Stem Cell Therapy Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Stem Cell Therapy Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Stem cell therapy Market size was valued at USD 12.11 Billion in 2022 and is poised to grow from USD 13.33 Billion in 2023 to USD 28.79 Billion by 2031, at a CAGR of 10.1% during the forecast period (2024-2031). 

The Global Stem cell therapy Market is highly competitive, with several key players operating in the industry. These companies are actively involved in research and development, strategic collaborations, mergers and acquisitions, and product launches to gain a competitive edge in the market. Here are some prominent players in the stem cell therapy market. The market is dynamic and competitive, with ongoing advancements and new entrants continually shaping the landscape. It is worth noting that the competitive landscape may evolve over time as companies pursue strategic collaborations, expand their product portfolios, and introduce new therapies to address unmet medical needs. 'Novartis AG (Switzerland)', 'Pfizer Inc. (US)', 'Mesoblast Limited (Australia)', 'Celgene Corporation (a subsidiary of Bristol Myers Squibb) (US)', 'TiGenix NV (a subsidiary of Takeda Pharmaceutical Company Limited) (Belgium)', 'Gamida Cell Ltd. (Israel)', 'Vericel Corporation (US)', 'Medipost Co., Ltd. (South Korea)', 'Astellas Pharma Inc. (Japan)', 'Osiris Therapeutics, Inc. (US)', 'NuVasive, Inc. (US)', 'Cynata Therapeutics Limited (Australia)', 'Cellular Dynamics International (a subsidiary of FUJIFILM Holdings Corporation) (US)', 'Lonza Group Ltd. (Switzerland)', 'Caladrius Biosciences, Inc. (US)', 'Athersys, Inc. (US)', 'Cytori Therapeutics, Inc. (US)', 'Holostem Terapie Avanzate S.r.l. (Italy)', 'Pluristem Therapeutics Inc. (Israel)', 'BioTime, Inc. (US)'

The rising burden of chronic diseases, such as cardiovascular disorders, neurodegenerative conditions, and orthopedic injuries, is a significant driver for the stem cell therapy market. Stem cell therapies offer the potential to regenerate damaged tissues and organs, providing new treatment options for patients with limited or no effective alternatives.

Increased Focus on Allogeneic Therapies: Allogeneic stem cell therapies, which use cells from a donor, have gained traction in the market. This approach offers advantages such as standardized and readily available cell sources, reduced manufacturing costs, and potential off-the-shelf treatments. Many companies are shifting their focus towards developing allogeneic cell therapy products, leading to an expanding pipeline of clinical trials and product development in this area.

In 2022, North America dominated the stem cell therapy market with the largest revenue share of 44.56%. This can be attributed to several factors, including the presence of innovative companies and key market players in the region, leading to a higher penetration of stem cell therapy products. North America is known for its strong biotechnology industry, extensive research and development activities, and a focus on promoting personalized medicines. These factors contribute to the region's leading position in the market. Additionally, the growth in North America is further supported by government initiatives aimed at promoting stem cell therapies.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Stem Cell Therapy Market

Product ID: SQMIG35H2162

$5,300
BUY NOW GET FREE SAMPLE